Subcutaneous Entyvio hits Crohn’s primary endpoint, misses secondary by Anna Smith | Feb 17, 2020 | News | 0 If approved, the drug could have huge benefits for patients as they could self-administer their therapy from home. Read More
Chiesi announces two successful sets of asthma data by Anna Smith | Oct 17, 2019 | News | 0 24% of asthma patients have difficult-to-treat or severe versions of the disease. Read More
United Theraputics ends esuberaprost trial early by Anna Smith | Apr 9, 2019 | News | 0 The company kept the announcement short, but said the study did not meet its primary endpoint. Read More